Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Sanofi–GSK COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/Sanofi–GSK_COVID-19_vaccine

    The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein, which is produced in insect cells via a baculovirus vector. It also includes an adjuvant made by GSK. It uses the same technology as Sanofi's Flublok influenza vaccine. [ 7][ 8]

  3. GSK plc - Wikipedia

    en.wikipedia.org/wiki/GSK_plc

    GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

  4. M72/AS01E - Wikipedia

    en.wikipedia.org/wiki/M72/AS01E

    M72/AS01E. M72/AS01E is an experimental tuberculosis vaccine. If approved, it would be the first vaccine for tuberculosis in more than a century after the BCG vaccine. [1] [2]

  5. AOL Mail

    mail.aol.com

    You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.

  6. List of GSK plc products - Wikipedia

    en.wikipedia.org/wiki/List_of_GSK_plc_products

    Fendrix (hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)) Fluarix (trivalent) & Fluarix (quadrivalent) (seasonal influenza vaccine (3 strain and 4 strain)) FluLaval (trivalent) & FluLaval (quadrivalent) (seasonal influenza vaccine (3 strain and 4 strain)) Havrix (for hepatitis A vaccine, inactivated) Hepatyrix (for hepatitis A (inactivated ...

  7. GSK Sees Strong Demand For Vaccines and Asthma Drugs ... - AOL

    www.aol.com/finance/gsk-sees-strong-demand...

    Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% excluding COVID. Vaccines’ sales increased 16% at constant currency ...

  8. US FDA expands GSK's RSV vaccine approval to adults ... - AOL

    www.aol.com/news/us-fda-expands-gsks-rsv...

    In April, Pfizer said its vaccine succeeded in a trial evaluating it in adults under age 60, adding that it plans to submit for expanded approval of the vaccine in adults aged 18 to 59. GSK also ...

  9. AS03 - Wikipedia

    en.wikipedia.org/wiki/AS03

    AS03 (for "Adjuvant System 03") is the trade name for a squalene -based immunologic adjuvant used in various vaccine products by GlaxoSmithKline (GSK). It is used, for example, in GSK's A/H1N1 pandemic flu vaccine Pandemrix. It is also in Arepanrix and the Q-pan for H5N1 influenza. [1] A dose of AS03 adjuvant contains [2] In the 2009 influenza ...